abstract |
The invention provides dual agonist compounds that exhibit agonist activity with . respect to both human thrombopoeitin c-Mpl receptor and human IL-3 receptor.. The invention provides dual agonist compounds that include dual agonist polypeptides, and also provides related nucleic acids, conjugates, vectors, cells, and methods of producing and using the dual agonist compounds. |